Clinical Trial Update: Minimal Residual Disease-guided Adjuvant Therapy for Gastric Cancer [NA]

View source ↗

Summary

This clinical trial update reports an ongoing study of minimal residual disease-guided adjuvant therapy for stage II-III gastric cancer; the trial is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Stage II-III Gastric Cancer | NA | Status: ACTIVE_NOT_RECRUITING